The Efficacy of Metformin Produced by Pars Mino Co. in Comparison With Canadian Apotex Co. in Glycemic Control of Diabetic Patients.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
Most Recent Events
- 01 Nov 2010 New trial record
- 26 Oct 2010 Biomarkers information updated